{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:11:27Z","timestamp":1790431887374,"version":"4.1.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.clml.2023.11.003","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T12:36:48Z","timestamp":1700829408000},"page":"e67-e77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Impact of Time From Diagnosis to Initiation of Chemotherapy on Survival of Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma in the Veterans Health Administration"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5498-2351","authenticated-orcid":false,"given":"Gabriel","family":"Roman Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohra","family":"Nooruddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8190-1809","authenticated-orcid":false,"given":"Sophia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana Tai","family":"Lucero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snegha","family":"Ananth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0341-0641","authenticated-orcid":false,"given":"Michael","family":"Mader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8147-4504","authenticated-orcid":false,"given":"Esteban","family":"Toro Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clml.2023.11.003_bib0001","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse large B-cell lymphoma","volume":"384","author":"Sehn","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.clml.2023.11.003_bib0002","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41408-022-00637-1","article-title":"Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989\u20132018","volume":"12","author":"Durmaz","year":"2022","journal-title":"Blood Cancer J"},{"issue":"23","key":"10.1016\/j.clml.2023.11.003_bib0003","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.2019002729","article-title":"International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI","volume":"135","author":"Ruppert","year":"2020","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.clml.2023.11.003_bib0004","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.30072","article-title":"Assessment of time-to-treatment initiation and survival in a cohort of patients with common cancers","volume":"3","author":"Cone","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.clml.2023.11.003_bib0005","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1038\/s41598-021-82615-4","article-title":"Importance of diagnosis-to-treatment interval in newly diagnosed patients with diffuse large B-cell lymphoma","volume":"11","author":"Yoshida","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.clml.2023.11.003_bib0006","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/bjh.15224","article-title":"Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomas","volume":"181","author":"Olszewski","year":"2018","journal-title":"Br J Haematol"},{"issue":"16","key":"10.1016\/j.clml.2023.11.003_bib0007","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1200\/JCO.2017.76.5198","article-title":"Diagnosis-to-treatment interval is an important clinical factor in newly diagnosed diffuse large B-cell lymphoma and has implication for bias in clinical trials","volume":"36","author":"Maurer","year":"2018","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clml.2023.11.003_bib0008","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/10428194.2015.1055480","article-title":"Impact of time from diagnosis to initiation of curative chemotherapy on survival of patients with diffuse large B-cell lymphoma","volume":"57","author":"Hay","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.clml.2023.11.003_bib0009","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/bjh.13150","article-title":"Predictors of delay in diagnosis and treatment in diffuse large B-cell lymphoma and impact on survival","volume":"168","author":"Nikonova","year":"2015","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.clml.2023.11.003_bib0010","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1080\/10428194.2017.1422863","article-title":"The impact of time from diagnosis to treatment in diffuse large B-cell lymphoma","volume":"59","author":"Phipps","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.clml.2023.11.003_bib0011","doi-asserted-by":"crossref","first-page":"719","DOI":"10.6004\/jnccn.2020.7654","article-title":"Shorter diagnosis-to-treatment interval in diffuse large B-cell lymphoma is associated with inferior overall survival in a large, population-based registry","volume":"19","author":"Blunt","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.clml.2023.11.003_bib0012","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/heq.2018.0086","article-title":"Racial\/ethnic disparities in mortality across the veterans health administration","volume":"3","author":"Wong","year":"2019","journal-title":"Health Equity"},{"issue":"9","key":"10.1016\/j.clml.2023.11.003_bib0013","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s11606-023-08207-2","article-title":"Veterans Health Administration (VA) vs. non-VA healthcare quality: a systematic review","volume":"38","author":"Apaydin","year":"2023","journal-title":"J Gen Intern Med"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226502302181X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226502302181X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:39:41Z","timestamp":1708994381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S215226502302181X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S215226502302181X"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2023.11.003","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Time From Diagnosis to Initiation of Chemotherapy on Survival of Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma in the Veterans Health Administration","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2023.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}